Evogene Ltd. (EVGN) has released an update.
Evogene Ltd., an Israeli biotech firm, has entered into a sales agreement with Lake Street Capital Markets, LLC to potentially issue and sell up to $7.3 million of its ordinary shares. The sales will be conducted on an ‘at the market’ basis, contingent upon a series of terms and compliance with regulatory limitations. This move is part of an effort to raise capital, facilitated through the Agent’s network and expertise, under the current effective Registration Statement and related Prospectus Supplement filed with the SEC.
For further insights into EVGN stock, check out TipRanks’ Stock Analysis page.
